Inaction has consequences: Mail-order mifepristone is midterm game-changer
The article discusses the implications of the Biden administration's decision to allow mail-order access to the abortion drug mifepristone without doctor oversight. It highlights the potential impact on the upcoming midterm elections, particularly among pro-life voters. The FDA's actions regarding the drug could significantly influence voter enthusiasm and the political landscape.
- ▪The FDA has removed safety regulations on mifepristone, making it available via mail without doctor oversight.
- ▪Mifepristone is responsible for over two-thirds of abortions in the U.S., with significant health risks for women.
- ▪A recent poll indicates that a substantial portion of the GOP base disapproves of the current mail-order abortion scheme and may be less enthusiastic about voting if pro-life priorities are abandoned.
Opening excerpt (first ~120 words) tap to expand
Inaction on the abortion drug crisis will not come without consequences for this year’s midterm elections. As post-Dobbs v. Jackson Women’s Health Organization retaliation dressed as COVID-19 relief, the Biden Food and Drug Administration removed the very last of any common-sense safety regulations on the abortion drug, mifepristone, making the dangerous drug available on demand to the general public via mail without doctor oversight. The abortion drug is now responsible for more than two-thirds of abortions, killing around 700,000 unborn humans in the U.S. annually and injuring 1 in 10 women who take the drug. Correcting Biden’s error is not only the right thing to do, but it would be an easy way to energize the pro-life electorate ahead of the midterm elections.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
